The US Bankruptcy Court approved the disclosure statement on interim basis of Argos Therapeutics, Inc. on April 5, 2019. The debtor had filed its revised amended disclosure statement in the Court on April 4, 2019. April 5, 2019 has been fixed as voting record date. The deadline to vote on the plan is May 15, 2019 and the plan objection deadline is May 15, 2019. The confirmation hearing for the plan has been scheduled for May 29, 2019.